Company
United StatesPublic company, NASDAQ: GNLXGenelux Corporation (NASDAQ: GNLX), San Diego, CA – FDA Inspections
Inspection records and compliance data for Genelux Corporation in San Diego, California. 1 FDA inspection on record, last inspected March 02, 2015. Publicly traded as NASDAQ: GNLX.
Company Profile
This profile covers Genelux Corporation based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 2, 2015.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 2, 2015 | NAI | Biologics · Bioresearch Monitoring | 917474 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Genelux Corporation
Stock ticker
GNLX
Exchange
NASDAQ
Share price
$1.82
Market cap
$82.3M
Price as of
November 6, 2026
FEI Number
3011370962
Address
3030 Bunker Hill St Ste 310, San Diego, California 92109, United States
Country
United States
ID: ebf01c33-0cef-4f4a-a9f9-b5ffc03915b0